Investing

ARS Pharmaceuticals : SPRY

SPRY

Stock Data

$6.16

$0.61 (10.99%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

ARS Pharmaceuticals Inc is a biopharmaceutical firm based in San Diego, California, focused on innovating allergy care. Founded in 2015, it's pioneering 'neffy,' a needle-free, intranasal epinephrine spray designed to offer a quick, easy-to-use emergency treatment for severe allergic reactions, including anaphylaxis. This breakthrough aims to empower patients and caregivers by providing a more accessible alternative to traditional methods.

All ARS Pharmaceuticals Articles

4 Articles

Trey Thoelcke | Aug 7, 2025 at 8:45 AM EDT

Berkshire Hathaway Picks Up More of Warren Buffett’s Favorite Media Stock

Berkshire Hathaway has resumed acquiring shares of Warren Buffett's favorite media stock. Other insider buyers are focused on three biotech…

Joshua Rodriguez | Aug 11, 2024 at 10:13 AM EDT

5 Stocks Under $10 Growing 50% Or More

Are you looking for low-cost stocks to add to your portfolio? Doing so can be a challenge. After all, stocks…

Trey Thoelcke | Mar 31, 2024 at 8:55 AM EDT

Huge Insider Buying From Buffett, an NFL Team Owner, a New CEO

Warren Buffett boosts his stake in this tracking stock again, plus notable insider buying from an NFL team owner and…